Aethlon Medical, Inc. Stock
Aethlon Medical, Inc. Stock price
Key metrics
Is Aethlon Medical, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?
As a Free StocksGuide user, you can view scores for all 6,967 stocks worldwide.
Aethlon Medical, Inc. Stock Analysis
Analyst Opinions
8 Analysts have issued a Aethlon Medical, Inc. forecast:
Analyst Opinions
8 Analysts have issued a Aethlon Medical, Inc. forecast:
Financial data from Aethlon Medical, Inc.
| Sep '24 |
+/-
%
|
||
| Revenue | - - |
-
|
|
| Gross Profit | - - |
-
|
|
| EBITDA | -11 -11 |
3%
3%
|
EBIT (Operating Income) EBIT | -12 -12 |
3%
3%
|
| Net Profit | -11 -11 |
3%
3%
|
|
In millions USD.
Don't miss a Thing! We will send you all news about Aethlon Medical, Inc. directly to your mailbox free of charge.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Aethlon Medical, Inc. Stock News
Company Profile
Aethlon Medical, Inc. is a therapeutic technology company, which focuses on addressing global health and biodefense needs. It develops Aethlon Hemopurifier, a medical device that targets the elimination of circulating viruses and tumor-secreted exosomes that promote cancer progression. The firm operates through two segments: Aethlon and ESI. The Aethlon segment involves in therapeutic business activities. The ESI segment consists of diagnostic business activities. The company was founded by James A. Joyce in May 1998 and is headquartered in San Diego, CA.
| Head office | United States |
| CEO | James Frakes |
| Employees | 14 |
| Founded | 1991 |
| Website | www.aethlonmedical.com |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
